High durable CR rates and preliminary safety profile for JCAR017 in R/R aggressive b-NHL (TRANSCEND NHL 001 Study): A defined composition CD19-directed CAR T-cell product with potential for outpatient administration Meeting Abstract


Authors: Abramson, J. S.; Siddiqi, T.; Palomba, M. L.; Gordon, L. I.; Lunning, M. A.; Arnason, J. E.; Wang, M.; Forero-Torres, A.; Albertson, T.; Dehner, C.; Garcia, J.; Li, D.; Xie, B.; Maloney, D. G.
Abstract Title: High durable CR rates and preliminary safety profile for JCAR017 in R/R aggressive b-NHL (TRANSCEND NHL 001 Study): A defined composition CD19-directed CAR T-cell product with potential for outpatient administration
Meeting Title: 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 5 Suppl.
Meeting Dates: 2018 Jan 25-27
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-10
Language: English
ACCESSION: WOS:000436177700115
DOI: 10.1200/JCO.2018.36.5_suppl.120
PROVIDER: wos
Notes: Meeting Abstract: 120 -- Source: Wos
Altmetric Score
MSK Authors
  1. Maria Lia Palomba
    118 Palomba